| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $878.0M | — | +10.3% |
| Cost of Revenue | $690.0M | — | +10.6% |
| Gross Profit | $188.0M | — | +9.3% |
| R&D Expense | $29.0M | — | +3.6% |
| SG&A Expense | $115.0M | — | +7.5% |
| Operating Income | $69.0M | — | +11.3% |
| Interest Expense | $20.0M | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $328.0M | -8.6% | -12.1% |
| Accounts Receivable | $818.0M | +1.7% | -2.2% |
| Inventory | $489.0M | +3.4% | +2.1% |
| Current Assets | $1.77B | +0.5% | -1.2% |
| Total Assets | $3.80B | -0.4% | +1.4% |
| Current Liabilities |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $53.0M | — | +32.5% |
| Investing Cash Flow | -$32.0M | — | +8.6% |
| Financing Cash Flow | -$50.0M | — | +57.3% |
| +5.3% |
| Pre-tax Income | $57.0M | — | +14.0% |
| Income Tax | $20.0M | — | -16.7% |
| Net Income | $37.0M | — | +42.3% |
| EPS (Basic) | $0.98 | — | +53.1% |
| EPS (Diluted) | $0.96 | — | +52.4% |
| $970.0M |
| +2.4% |
| +0.2% |
| Long-term Debt | $969.0M | -0.1% | -2.0% |
| Total Liabilities | $2.25B | +1.0% | +1.9% |
| Stockholders' Equity | $1.55B | -2.4% | +0.8% |